When it comes to technology trends, the cloud computing trend that generated so much success for the largest tech companies can no longer really be… Read More »2 Truly Transformative Tech Trends To Focus On – And 2 Stocks Set To Profit From Those Trends
Of four frontrunners in the race for a vaccine for COVID-19 – Moderna, Pfizer and BioNTech, Inovio Pharmaceuticals, and AstraZeneca – is there any indication… Read More »Which Frontrunner’s COVID-19 Vaccine Candidate May Hold The Most Promise – And Why?
Long periods of underperformance by an asset class have historically been followed by extended periods of outperformance, so when it comes to finding the next… Read More »4 Small-Caps Set To Surge
Shares of vaccine specialist Vaxart have exploded an astonishing 4748% so far this year, as investors have piled into the company on the hopes that… Read More »After An Incredible 4748% Surge, Still Plenty Of Room To Run For Vaxart?
Despite the rejuvenated “risk-on” tone in the market at the moment, today’s article notes that traders are pricing in a lot of risk at one… Read More »Electoral Options: How – And Why – Traders Are Pricing In A Lot Of Risk In Early November
When it comes to biotech’s performance over the last several weeks, the author of today’s article notes that “Part of the sector’s rise is undoubtedly… Read More »4 Biotech Stocks Worthy Of Close Attention
What’s clear is that, having surged 2,819% in the past 12 months (and 351% so far this year in the face of a market meltdown),… Read More »The Massive – And Mysterious – Rally Of The World’s Best-Performing Stock
Given the ability of earnings reports to catapult stock prices higher in a short period of time, the authors of today’s article state “It’s no… Read More »A Better Way To Play The Earnings Game?
There is currently only one drug that has demonstrated the potential to be a safe and effective treatment for COVID-19 in clinical trials: Gilead Sciences’… Read More »Remdesivir’s COVID-19 Success Could Create A Big “Piggyback” Opportunity For This Under-The-Radar Biotech
FDA approval is the ultimate prize in the biotech industry – and one of the few major catalysts for biotech stocks. As a result, having… Read More »2 “Compelling” Biotech Stocks That Just Won The Ultimate Prize (FDA Approval)